7.00% p.a. Multi Barrier Reverse Convertible
Eli Lilly, Novo Nordisk
Valor
135619215
SIX Symbol
OSLRCH
ISIN
CH1356192158
Identifiers
135619215
CH1356192158
OSLRCH
Yield Enhancement
Barrier Reverse Convertible
Callable Multi Barrier Reverse Convertible
1230
Parameters
Raiffeisen Switzerland B.V., Amsterdam, The Netherlands
Raiffeisen Switzerland Cooperative, St. Gallen, Switzerland
Quarterly
7.00% p.a.
Cash Settlement or Delivery of Underlying
Dirty (accrued interest included)
100%
CHF 1'000.00
CHF
Listed
Yes
Life Cycle
2 Years
02 Aug 2024
09 Aug 2024
09 Aug 2024
19 Aug 2024
19 Aug 2024
12 Aug 2026
19 Aug 2026
Barrier
57.00%
Continuous barrier observation (american)
09 Aug 2024 - 12 Aug 2026
Yes
Product Specific Features
100.00%
Performance
Name Market Price Initial Fixing Level Barrier Level Strike Level Distance to Strike
{{ underlyings['67114601'].currency }} {{ underlyings['67114601'].underlyingFeed.spot | number:2 }}
USD 891.68 USD 508.26 USD 891.68 -8.77%
{{ underlyings['67519173'].currency }} {{ underlyings['67519173'].underlyingFeed.spot | number:2 }}
DKK 918.60 DKK 523.60 DKK 918.60 -77.95%
Coupons
Payment Date Amount
19 Nov 2024 1.75%
19 Feb 2025 1.75%
19 May 2025 1.75%
19 Aug 2025 1.75%
19 Nov 2025 1.75%
19 Feb 2026 1.75%
20 May 2026 1.75%
19 Aug 2026 1.75%
Early Redemption
Observation Date Redemption Amount
12 Aug 2025 100.00%
12 Nov 2025 100.00%
12 Feb 2026 100.00%
12 May 2026 100.00%
Eli Lilly
Cannot load the chart. Please try again later
Eli Lilly
{{ underlyings['67114601'].currency }} {{ underlyings['67114601'].underlyingFeed.spot | number:2 }}
LLY UN
USD
USD 891.68
USD 508.2576
USD 891.68
-8.7733%
NYSE
Novo Nordisk
Cannot load the chart. Please try again later
Novo Nordisk
{{ underlyings['67519173'].currency }} {{ underlyings['67519173'].underlyingFeed.spot | number:2 }}
NOVOB DC
DKK
DKK 918.60
DKK 523.602
DKK 918.60
-77.9543%
OMX Nordic Exchange Copenhagen
Yes (12 Mar 2025)